Cargando…

Are matrix metalloproteinases relevant therapeutic targets for prostate cancer bone metastasis?

Detalles Bibliográficos
Autores principales:	Bonfil, R.D., Fridman, R., Mobashery, S., Cher, M.L.
Formato:	Texto
Lenguaje:	English
Publicado:	Multimed Inc. 2008
Materias:	Updates and Developments in Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2528310/ https://www.ncbi.nlm.nih.gov/pubmed/18769612

Ejemplares similares

Retinoids, vitamin D, invasion, and metastasis
por: Tokar, E.J., et al.
Publicado: (2006)

Protein tyrosine phosphatases: new markers and targets in oncology?
por: Hardy, S., et al.
Publicado: (2008)

Update of human and mouse matrix metalloproteinase families
por: Jackson, Brian C, et al.
Publicado: (2010)

Radiation oncology: Times of practice change
por: Freeman, C.R., et al.
Publicado: (2007)

The role of dna hypermethylation and demethylation in cancer and cancer therapy
por: Szyf, M.
Publicado: (2008)

Anal cancer and human papillomaviruses in heterosexual men
por: Nyitray, A.
Publicado: (2008)

Cancer and thrombosis: recent advances
por: Solymoss, S.
Publicado: (2008)

Targeting transforming growth factor β to enhance cancer immunotherapy
por: Hahn, T., et al.
Publicado: (2006)

Radiofrequency ablation and cryoablation of renal tumours
por: Kwan, K.G., et al.
Publicado: (2007)

Radiolabelled monoclonal antibodies in the treatment of metastatic cancer
por: Goldenberg, D.M.
Publicado: (2007)

Recent advances in the tumour biology of the GPI-anchored carcinoembryonic antigen family members CEACAM5 and CEACAM6
por: Chan, C.H.F., et al.
Publicado: (2007)

Hepatocyte growth factor and the hepatocyte growth factor receptor signalling complex as targets in cancer therapies
por: Jiang, W.G.
Publicado: (2007)

Cancer symptom control trials: how may we advance this field?
por: MacDonald, N.
Publicado: (2007)

The antitumour activities of statins
por: Takahashi, H.K., et al.
Publicado: (2007)

Role of vaccine therapy in cancer: biology and practice
por: Schlom, J., et al.
Publicado: (2007)

Genomancy: predicting tumour response to cancer therapy based on the oracle of genetics
por: Williams, P.D., et al.
Publicado: (2009)

Electrochemotherapy of tumours
por: Sersa, G., et al.
Publicado: (2009)

Exosomes in tumour immunity
por: Clayton, A., et al.
Publicado: (2009)

Promising agents for chemoprevention of skin cancer
por: Stratton, S.P., et al.
Publicado: (2006)

Comparing the results of bisphosphonate use in clinical trials with actual practice: a case of apples and oranges?
por: Gainford, M.C., et al.
Publicado: (2006)

Receptor tyrosine kinases: role in cancer progression
por: Sangwan, V., et al.
Publicado: (2006)

Matrix metalloproteinases as therapeutic targets in breast cancer
por: Kwon, Mi Jeong
Publicado: (2023)

ACADL Functions as a Tumor Suppressor in Hepatocellular Carcinoma Metastasis by Inhibiting Matrix Metalloproteinase 14
por: Guo, Danfeng, et al.
Publicado: (2022)

High matrix metalloproteinase-9 expression induces angiogenesis and basement membrane degradation in stroke-prone spontaneously hypertensive rats after cerebral infarction
por: Hou, Huilian, et al.
Publicado: (2014)

Role of Matrix Metalloproteinases in Angiogenesis and Cancer
por: Quintero-Fabián, Saray, et al.
Publicado: (2019)

The multifaceted roles of matrix metalloproteinases in lung cancer
por: Wei, Cui
Publicado: (2023)

Comparative Analysis of Immunopathological Features of Lichen Planopilaris and Female Patients with Frontal Fibrosing Alopecia
por: Cerqueira, Emanuella RD, et al.
Publicado: (2016)

BENIGN BONE TUMORS AND TUMOR-LIKE BONE LESIONS: TREATMENT UPDATE AND NEW TRENDS
por: Nogueira Drumond, José Marcos
Publicado: (2015)

Microbes and colorectal cancer: is there a relationship?
por: Uronis, J.M., et al.
Publicado: (2009)

Pretargeted radioimmunotherapy in the treatment of metastatic medullary thyroid cancer
por: Kraeber–Bodéré, F., et al.
Publicado: (2009)

Update to a randomized controlled trial of lutetium-177-PSMA in Oligo-metastatic hormone-sensitive prostate cancer: the BULLSEYE trial
por: Privé, Bastiaan M., et al.
Publicado: (2021)

Matrix metalloproteinases and tissue inhibitors in multiple myeloma: promote or inhibit?
por: Li, Yan-Ying, et al.
Publicado: (2023)

Statistical analysis plan for the Urodynamics for Prostate Surgery Trial; Randomised Evaluation of Assessment Methods (UPSTREAM)
por: Young, Grace J., et al.
Publicado: (2017)

Feasibility of Comparative Health Research Outcome of Novel Surgery in prostate cancer (IP4-CHRONOS): statistical analysis plan for the randomised feasibility phase of the CHRONOS study
por: Day, Emily, et al.
Publicado: (2021)

Mathematical Modeling of Cancer Invasion: The Role of Membrane-Bound Matrix Metalloproteinases
por: Deakin, Niall E., et al.
Publicado: (2013)

Role of Interleukin-1 family in bone metastasis of prostate cancer
por: Tong, Yuanhao, et al.
Publicado: (2022)

Gene expression analysis of bone metastasis and circulating tumor cells from metastatic castrate-resistant prostate cancer patients
por: Cho, Won Jin, et al.
Publicado: (2016)

Different roles of matrix metalloproteinase 2 in osteolysis of skeletal dysplasia and bone metastasis
por: Li, Xiumao, et al.
Publicado: (2021)

Global scientific trends on matrix metalloproteinase and osteosarcoma: A bibliometric and visualized analysis
por: Wu, Xin, et al.
Publicado: (2023)

Statistical analysis plan for the EuroHYP-1 trial: European multicentre, randomised, phase III clinical trial of the therapeutic hypothermia plus best medical treatment versus best medical treatment alone for acute ischaemic stroke
por: Winkel, Per, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_2sidthep6pvs5tec98jc6h4a1p